Generate:Biomedicines

How do you redefine what’s possible in science? Just ask John Ingraham, our Head of Machine Learning, who has just been named one of Boston Business Journal's 40 Under 40 for 2024. John is a pioneer in the field of #GenerativeBiology, applying his innovative thinking in #ML and #AI to create tools that are revolutionizing drug discovery. His work in developing foundational technologies for protein structure and sequence generation is at the heart of our platform and underlies all of our programs. Beyond his technical achievements, John has also built a world-leading team of machine learning scientists and has been a recognized thought leader in the fields of #ProteinScience and #MachineLearning.  Join us in celebrating John’s achievements and learn more about the 2024 honorees: https://lnkd.in/eKaA94-F #ProgrammingBiology | #BBJ4040

We’re excited to welcome Alex Therien, as our new Senior Vice President of Drug Design and Preclinical Development. Alex will be pivotal in advancing the integration and mutual reinforcement of our platform and portfolio.    With a robust background in drug discovery, including his leadership at Eikon Therapeutics and nearly 20 years at Merck, Alex has contributed to the development of five FDA-approved drugs. His expertise will drive #TeamGenerate’s efforts to enhance connectivity and collaboration across our programs.    As we forge ahead with bold innovation and transformative progress, we’re thrilled to have Alex as part of our journey.     #ProteinEngineering | #GenerativeAI 

Curious about the future of biologics? We’re not just envisioning it—we’re engineering it. Next week, Adam Root, our Head of Protein Science, will take the stage at the "From the Laboratory to the Clinic: 25 Years of Biological Therapy Conference" to showcase how we're transforming biologics from a discovery-driven process to an engineering-led discipline. Adam will dive into how #GenerativeAI and #MachineLearning are not just speeding up the journey from concept to clinic but also enhancing the quality and precision of therapeutics. He'll highlight our work on generating monoclonal antibodies that are advancing treatments in critical areas such as respiratory diseases, inflammation, and immune system modulation—showing that the future of medicine is not just being imagined; it’s being built. Learn more about how we’re pushing boundaries and redefining what’s possible: https://lnkd.in/gCWQ-ymD #ProgrammingBiology | #UnapologeticallyScientific 

How do we inspire the next generation of engineers and scientists? By inviting them into our world! Last week, #TeamGenerate was thrilled to host our annual #BringYourKidsToWorkDay. We sparked curiosity with our #UnapologeticallyScientific spirit while giving our young guests a special glimpse into where we work. It was a perfect opportunity to show our children what we do and spark their interest in the world of programmable biology. By fostering curiosity and helping our future #STEM leaders see the impact of our work, we stay true to our mission of transforming human health. #FiercelyUnited | #RelentlesslyCurious

#TeamGenerate doesn't just work—we innovate, collaborate, and lead with a shared mission to revolutionize how medicines are discovered and developed. Our recent All-Hands Meeting at our Andover campus was a celebration of this spirit. From honoring our #FiercelyUnited team with our Mindset Award to enjoying our annual summer BBQ and cornhole tournament, we showcased what makes us uniquely Generate. If you're passionate about pushing boundaries and working alongside the best in the industry, explore our career opportunities and become part of a team that is #UnapologeticallyScientific and values a strong sense of community. Learn more here: https://lnkd.in/gKaKkEGJ #ProgrammingBiology I #GenerativeAI

Ready to harness the power of #AI to revolutionize drug discovery? Join the innovative minds blending computation, experimentation, and therapeutic development to pioneer #GenerativeBiology and create breakthrough therapeutics. Now We Can. Can you? Apply to one of the jobs listed below. Scientist I, Machine Learning  https://lnkd.in/eQvMN63f      Senior Technical Program Manager, Computational Sciences   https://lnkd.in/eDgbNHPE     Principal Scientist, Protein Analytics & Biophysics- Target Binding  https://lnkd.in/exYY6R7i      Scientist I, Microbioreactor Scientist  https://lnkd.in/eDj5SbYr      Director, Procurement  https://lnkd.in/eyrVjzGz     Total Rewards Analyst/Senior Analyst  https://lnkd.in/e3Mhu7wk  

Ready to explore AI’s impact on the future of medicine? On August 22, our own Alexandra Snyder, MD will join leading industry experts at the TINS: Technology Innovation Studio to discuss how #AI is revolutionizing drug discovery, accelerating development processes, and unlocking new possibilities in medicine. The panel will also features Derek Lowe from Novartis Institute For Biomedical Research (NIBR), Anne Carpenter from Broad Institute of MIT and Harvard, Jen Nwankwo, Ph.D. from 1910 Genetics, and will be moderated by Rhie-young Lim from LifeCanvas Technologies Inc. Don’t miss out! Learn more here: https://lu.ma/6ddz256g #ProteinEngineering | #GenerativeBiology

Did you know that when we launched nearly six years ago, we estimated there were only about 90 people on the planet skilled at the intersection of #machinelearning and #proteinengineering? Hear our CEO Michael Nally discuss how #TeamGenerate is fostering a unique, collaborative culture in CorrDyn’s Data in Biotech interview with Ross Katz. Mike highlights how we blend computation, experimentation, and therapeutic development to drive innovation. Are you ready to span multiple disciplines and drive groundbreaking innovations? Explore career opportunities here: https://lnkd.in/gKaKkEGJ 👇 Watch the clip to hear more from Mike. #UnapologeticallyScientific | #IntrinsicallyDigital 

Curious how #AI is transforming drug development? On August 14, our EVP, Head of R&D, Alexandra Snyder, MD, will join industry leaders for #Bioverse Episode 12. Together, they will explore the advantages and limitations of AI in drug discovery of small molecules and biologics, clinical development, ethical considerations, IP protection, collaboration opportunities, and future trends. Don’t miss this opportunity—tune into this free webinar by following the link below 👇 https://lnkd.in/eC6_u5kn #UnapologeticallyScientific | #ProgrammingBiology InScienceWeTrust Community , Leon 'Jun' T. , Lily Zhang, Shijing (Nora) Luo, Sharon Chen , and Lipeng Lai

We are excited to announce Wiskensley Pierre (Wiz) as the recipient of our #FiercelyUnited Mindset Award! This award recognizes those who focus on collective achievement, trust, and accountability - demonstrating the true spirit of teamwork within #TeamGenerate. Wiz exemplifies what it means to be fiercely united by always supporting diverse perspectives and fostering a cohesive team environment. This summer, Wiz also completed a master’s in cybersecurity, reinforcing our defense against these threats and ensuring our collective security. Want to join a team that values collaboration and innovation? Explore opportunities with us: https://lnkd.in/gKaKkEGJ #ProgrammingBiology | #NowWeCan